BioLife Plasma Services
The Process Technology & Innovation Lead – DS Downstream defines and drives the global technology and innovation strategy for Drug Substance Downstream manufacturing across Takeda's network. This role leads the development and deployment of advanced process technologies, automation, digital solutions, and AI-enabled capabilities to enhance manufacturing competitiveness and efficiency. The position involves shaping future manufacturing capabilities and delivering sustainable business value through strategic innovation and cross-functional collaboration.
Headquarters
Bannockburn, Illinois, United States
Company Size
5001-10000 employees
BioLife Plasma Services operates a network of plasma collection centers that collect donated human plasma used to manufacture life‑saving plasma‑derived therapies. The company focuses on donor safety and convenience, offering screening, regulated collection procedures, appointment scheduling, and compensation/rewards to encourage repeat donations. BioLife partners with biopharmaceutical manufacturers and maintains rigorous quality and regulatory standards to supply plasma for treatments such as immune deficiencies, bleeding disorders, and other therapeutic uses.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for BioLife Plasma Services.
Associate Director, Drug Substance Manufacturing – Downstream Process
Vera Therapeutics, Inc.
Senior Engineer, Process Development (Downstream)
Amgen
Associate Engineer, Process Development - Downstream
Amgen
Specialist Manufacturing: NPI, Process Owner
Amgen
Director, Process Development Downstream
avidbio
Senior Process Engineer - Manufacturing Sciences & Technology, Downstream
Catalent